Clinical Trial Update: Long-Term Follow-up Study of Patients Who Received PB127 Ultrasound Imaging Agent

View source ↗

Summary

Long-term follow-up results are reported for patients who received the PB127 ultrasound imaging agent in a terminated study involving coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• PB127

Snippet

Sponsor: Point Biomedical | Conditions: Coronary Artery Disease | Status: TERMINATED